| | Scope | Document part | Language | Document |
|---|
| USA 21 CFR Part 11 09-Apr-2025 § 11.100 | G | § 11.100 | EN | USA 21 CFR Part 11 09-Apr-2025 |
| USA 21 CFR Part 11 09-Apr-2025 § 11.200 | G | § 11.200 | EN | USA 21 CFR Part 11 09-Apr-2025 |
| USA 21 CFR Part 11 09-Apr-2025 § 11.30 | G | § 11.30 | EN | USA 21 CFR Part 11 09-Apr-2025 |
| USA 21 CFR Part 312 09-Apr-2025 § 312.53 (c) | HM | § 312.53
(c) | EN | USA 21 CFR Part 312 09-Apr-2025 |
| USA 21 CFR Part 312 09-Apr-2025 § 312.58 | HM | § 312.58 | EN | USA 21 CFR Part 312 09-Apr-2025 |
| USA 21 CFR Part 312 09-Apr-2025 § 312.68 | HM | § 312.68 | EN | USA 21 CFR Part 312 09-Apr-2025 |
| USA 21 CFR Part 312 09-Apr-2025 § 312.70 | HM | § 312.70 | EN | USA 21 CFR Part 312 09-Apr-2025 |
| USA 21 CFR Part 312 09-Apr-2025 § 312.85 | HM | § 312.85 | EN | USA 21 CFR Part 312 09-Apr-2025 |
| USA 21 CFR Part 320 09-Apr-2025 § 320.22 | HM | § 320.22 | EN | USA 21 CFR Part 320 09-Apr-2025 |
| USA 21 CFR Part 50 09-Apr-2025 § 50.20 | G | § 50.20 | EN | USA 21 CFR Part 50 09-Apr-2025 |
| USA 21 CFR Part 50 09-Apr-2025 § 50.25 (a) - (b) | G | § 50.25
(a) - (b) | EN | USA 21 CFR Part 50 09-Apr-2025 |
| USA 21 CFR Part 50 09-Apr-2025 § 50.25 (e) | G | § 50.25
(e) | EN | USA 21 CFR Part 50 09-Apr-2025 |
| USA 21 CFR Part 50 09-Apr-2025 § 50.3 | G | § 50.3 | EN | USA 21 CFR Part 50 09-Apr-2025 |
| USA 21 CFR Part 54 09-Apr-2025 § 54.1-001 | G | § 54.1 | EN | USA 21 CFR Part 54 09-Apr-2025 |
| USA 21 CFR Part 54 09-Apr-2025 § 54.1-002 | G | § 54.1 | EN | USA 21 CFR Part 54 09-Apr-2025 |
| USA 21 CFR Part 54 09-Apr-2025 § 54.4 disclosure | G | § 54.4
disclosure | EN | USA 21 CFR Part 54 09-Apr-2025 |
| USA 21 CFR Part 54 09-Apr-2025 § 54.4 list of investigators | G | § 54.4
list of investigators | EN | USA 21 CFR Part 54 09-Apr-2025 |
| USA 21 CFR Part 54 09-Apr-2025 § 54.6 | G | § 54.6 | EN | USA 21 CFR Part 54 09-Apr-2025 |
| USA 21 CFR Part 56 09-Apr-2025 - | G | - | EN | USA 21 CFR Part 56 09-Apr-2025 |
| USA 21 CFR Part 56 09-Apr-2025 § 56.104 | G | § 56.104 | EN | USA 21 CFR Part 56 09-Apr-2025 |
| USA 21 CFR Part 56 09-Apr-2025 § 56.104 (d) | G | § 56.104
(d) | EN | USA 21 CFR Part 56 09-Apr-2025 |
| USA 21 CFR Part 56 09-Apr-2025 § 56.105 | G | § 56.105 | EN | USA 21 CFR Part 56 09-Apr-2025 |
| USA 21 CFR Part 56 09-Apr-2025 § 56.110 (a) - (b) (1) | G | § 56.110
(a) - (b) (1) | EN | USA 21 CFR Part 56 09-Apr-2025 |
| USA 21 CFR Part 812 09-Apr-2025 § 812.145 | MD | § 812.145 | EN | USA 21 CFR Part 812 09-Apr-2025 |
| USA 21 CFR Part 812 09-Apr-2025 § 812.30 | MD | § 812.30 | EN | USA 21 CFR Part 812 09-Apr-2025 |
| USA 21 CFR Part 812 09-Apr-2025 § 812.42 | MD | § 812.42 | EN | USA 21 CFR Part 812 09-Apr-2025 |
| USA 21 CFR Part 812 09-Apr-2025 § 812.43 (c) (4) | MD | § 812.43
(c) (4) | EN | USA 21 CFR Part 812 09-Apr-2025 |
| USA 21 CFR Part 812 09-Apr-2025 § 812.43 (c) (5) | MD | § 812.43
(c) (5) | EN | USA 21 CFR Part 812 09-Apr-2025 |
| USA 45 CFR Part 160 09-Apr-2025 § 164.512 | G | § 164.512 | EN | USA 45 CFR Part 160 09-Apr-2025 |
| USA FDA - E6(R2) Good Clinical Practice: Integrated Addendum to ICH E6(R1): Guidance for Industry March 2018 - | G | - | EN | USA FDA - E6(R2) Good Clinical Practice: Integrated Addendum to ICH E6(R1): Guidance for Industry March 2018 |
| USA FDA INFORMATION SHEET - Recruiting Study Subjects, Guidance for Institutional Review Boards and Clinical Investigators Jan-1998 - | HM | - | EN | USA FDA INFORMATION SHEET - Recruiting Study Subjects, Guidance for Institutional Review Boards and Clinical Investigators Jan-1998 |